A clinician’s experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting
2008 (English)In: European Journal of Heart Failure, ISSN 1388-9842, Vol. 10, no 3, 260-266 p.Article in journal (Refereed) Published
The evaluation of natriuretic peptides has become increasingly valuable in a clinical setting, where information is often needed promptly.
Objectives: To compare the usefulness of the recently released Roche Cardiac Reader ® NT-proBNP assay against the Roche Elecsys® NT-proBNP laboratory system in a clinical setting.
Design and Results: Blood samples from 440 patients admitted for acute coronary syndromes, worsening of heart failure, or as policlinic heart failure patients were evaluated. The relation between the assays was analysed and the diagnostic concordance calculated. A good correlation was found between the assays (r=0.96, 95% CI: 0.94-0.97) with a diagnostic concordance of 0.93. A separate analysis was performed in the range where most clinical decisions are made (60-3000 ng/L), with a diagnostic concordance of 88%. The usefulness in a clinical setting where time is important was high.
Conclusion: The Roche Cardiac Reader® NT-proBNP assay has been evaluated in a clinical setting. The point-of-care method shows good results, although with a restricted analytical range compared with the reference.
Place, publisher, year, edition, pages
Institutionen för medicin och hälsa , 2008. Vol. 10, no 3, 260-266 p.
Heart failure, Natriuretic peptides, Point-of-care
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-11488DOI: 10.1016/j.ejheart.2008.01.005OAI: oai:DiVA.org:liu-11488DiVA: diva2:17914
Original publication: Alehagen U, and Janzon M, A clinician’s experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting, 2008, European Journal of Heart Failure, (10), 3, 260-266. http://dx.doi.org/10.1016/j.ejheart.2008.01.005. Copyright: Elsevier B.V., http://www.elsevier.com/2008-04-112008-04-112013-09-11